Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

NEW ORLEANS (WVUE) - If you have trouble affording prescription drugs, some independent pharmacists say that so-called ...

PORTLAND, GA, UNITED STATES, November 5, 2024 /EINPresswire / -- The global Implantable Insulin Pump Market was pegged at $2.67 billion in 2020, and is estimated to reach $6.44 billion by 2030, ...

Bashan declined to reveal how much the company owed creditors, but in its bankruptcy filing in U.S. Bankruptcy Court in ...

Part 2 of this series for Global Biosimilars Week dives into the complexities of payer and pharmacy benefit manager (PBM) ...

In September, the Federal Trade Commission took aim at big pharmacy benefits managers, including CVS subsidiary Caremark, accusing them of inflating insulin prices. “We are not surprised by the ...

CVS Health is one of three pharmacy benefit managers targeted in a lawsuit from the Federal Trade Commission, which has accused the companies of driving up the price of insulin. The three firms ...